Mental health challenges such as depression, anxiety, and insomnia are becoming increasingly prevalent worldwide, and the World Health Organization (WHO) estimates that almost 4% of the global population will suffer from depression at some point in their lives[1]. In regions like the UK, US and Europe, limited resources, stigma, and long waiting lists have created a persistent treatment gap, and technology is stepping in to fill it.
Digital mental health technologies (DMHTs), including apps, platforms and AI-driven tools, are transforming how individuals engage with mental health support. Yet, with innovation comes regulation, and to provide greater clarity in this rapidly evolving field, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has released new guidance on how to classify and regulate DMHTs, including those powered by AI and large language models.
The regulatory landscape for AI-powered DMHTs
As AI-powered tools become increasingly embedded in healthcare pathways, the MHRA’s move toward a more structured, transparent approach is a welcome development. By clarifying what constitutes a regulated medical device and setting expectations for safety, functionality, and clinical purpose, the guidance helps align innovation with patient safety.
Incorporating AI or LLMs into their mental health technologies introduces unique challenges around transparency, data integrity, and clinical performance and understanding how such tools will be assessed is crucial. The MHRA expects robust evidence demonstrating that the AI behaves reliably, ethically and within the intended scope of use and manufacturers must also show how they manage updates and learning algorithms over time.
Introducing IMed Consultancy’s latest whitepaper
To help make sense of these changes, IMed Consultancy has published a free whitepaper: “Mental Health Goes Digital: A Blueprint for Digital Health Medical Technologies (DHMTs)”, providing aa detailed overview of the new guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), helping developers determine whether their digital tools should be regulated as medical devices, or not. It offers practical insights into the classification criteria, regulatory pathways, and evolving expectations for AI-powered tools, including those incorporating large language models and generative AI.
A glimpse of what you’ll find
The whitepaper outlines the essential regulatory considerations shaping digital mental health today, offering expert insight on how companies can prepare for compliance while continuing to innovate and providing clarity on critical themes such as:
- How to determine whether your app or platform may be considered a medical device
- What the new MHRA guidance means for digital tools, particularly those powered by AI and generative AI
- How to approach UK compliance strategically, ensuring smoother approval and market readiness
It also reflects on the wider context, exploring how regulatory clarity can help drive innovation, improve patient safety, and support a sustainable digital health ecosystem.
A trusted partner for DMHT manufacturers
At IMed Consultancy, we support innovators, from start-ups to global manufacturers, in navigating the complexities of UK medical device regulation. Our specialists will help you determine whether your technology qualifies as a medical device, understand your regulatory obligations and prepare your compliance documentation with precision.
With the MHRA now setting a new standard for DMHTs, partnering with an experienced consultancy can help you move forward with confidence and ensure your innovation is both compliant and competitive.
Download Mental Health Goes Digital: A Blueprint for Digital Health Medical Technologies (DHMTs) today and drop us a line at hello@imedconsultancy.com to ensure your innovation remains compliant, competitive, and ready to meet the needs of a rapidly evolving healthcare environment.
- [1] WHO, Newsroom, Fact sheet, “Depressive disorder (depression)”, 31/03/2023, https://www.who.int/news-room/fact-sheets/detail/depression